Sandra Vedrick | Director, IR |
George Tidmarsh | President & CEO |
Dennis Mulroy | CFO |
Joon Lee | SunTrust Robinson |
Edward White | H.C. Wainwright |
Kip Bitok | Chardan |
Laura Christianson | Cowen & Company |
Kyung Yang | Jefferies |
Anupam Rama | JP Morgan |
Welcome to the La Jolla Pharmaceutical Company Third Quarter 2018 Financial Results Call. On today's call, La Jolla will be making forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to expectations regarding future events or future results of operations. These statements are only predictions or statements of current expectations and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from those anticipated by the forward-looking statements. La Jolla cautions listeners not to place undue reliance on any such forward-looking statements, which speak only as of today’s date.